September 5, 2023
Nobelpharma said on September 1 that UK regulatory authorities have granted approval for Hyftor (sirolimus topical gel) for the treatment of facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and pediatric patients aged six years and older. The...read more